Acute Intermittent Porphyria Treatment News and Symptoms Information

What is Acute Intermittent Porphyria (AIP)?

(Symptoms, Causes & Treatment)

According to the National Institutes of Health, Acute intermittent porphyria (AIP) is one of the liver (hepatic) porphyrias. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an enzyme also often called hydroxymethylbilane synthase. The low levels of PBGD are generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms, symptomatic individuals typically present with abdominal pain with nausea. Treatment is dependent on the symptoms.

See below for updated news and information regarding Acute Intermittent Porphyria including new medical research, treatment options and advancements. 

Latest Acute Intermittent Porphyria Treatment News and Research

Alnylam Reports Positive Interim Results from Ongoing Phase 1 …

Business Wire (press release)Sep 7, 2016
ASHE subjects have a mutation in the porphobilinogen deaminase (PBGD) gene as found in acute intermittent porphyria (AIP) and have …

My Journey From Doctor to Chronic Pain Patient

Pain News NetworkJan 7, 2016
After about a week of tests, the doctors were able to diagnose me with a rare genetic metabolic disease called acute intermittent porphyria.

For more information, please visit the Genetic and Rare Diseases Information Center

healthcare careers

science careers

If you have experience dealing with this disease or condition (especially with regard to symptoms, diagnosis, causes or treatment), please share below: